INTERNATIONAL PATENT: MVRIX CO.,LTD., 엠브릭스 주식회사 FILES APPLICATION FOR "NANODISC COMPRISING ANGIOTENSIN-CONVERTING ENZYME 2 AND FC FRAGMENT AND USE THEREOF"

GENEVA, April 16 -- MVRIX CO.,LTD. (B-dong, 29floor #2944, 27 Dongtancheomdansaneop 1-roHwaseong-siGyeonggi-do 18469), 엠브릭스 주식회사 (경기도화성시동탄첨단산업1로 27, B동 29층 2944호) filed a patent application (PCT/KR2024/015232) for "NANODISC COMPRISING ANGIOTENSIN-CONVERTING ENZYME 2 AND FC FRAGMENT, AND USE THEREOF" on Oct 07, 2024. With publication no. WO/2025/075477, the details related to the patent application was published on Apr 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual ...